Is MTCR or ORCC a better dividend investment in 2026?

MTCR currently yields 344.00% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: MTCR offers higher current income.

What is the dividend yield difference between MTCR and ORCC?

MTCR has a forward dividend yield of 344.00% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 334.21 percentage points.

Home › Compare › MTCR vs ORCC

MTCR vs ORCC: Dividend Comparison 2026

MTCR yields 344.00% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MTCR wins by $3877.91M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MTCR

● Live price

344.00%

Share price

$0.58

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3877.94M

Annual income

$2,467,114,396.16

Full MTCR calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — MTCR vs ORCC

📍 MTCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MTCR	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MTCR + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MTCR pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTCR

Annual income on $10K today (after 15% tax)

$29,239.77/yr

After 10yr DRIP, annual income (after tax)

$2,097,047,236.74/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, MTCR beats the other by $2,097,047,235.85/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTCR + ORCC for your $10,000?

MTCR: 50%ORCC: 50%

100% ORCC50/50100% MTCR

Portfolio after 10yr

$1938.98M

Annual income

$1,233,557,198.60/yr

Blended yield

63.62%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

MTCR

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-5.6

Piotroski

2/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTCR buys

ORCC buys

No recent congressional trades found for MTCR or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMTCRORCC

Forward yield	344.00% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$3877.94M ✓	$21.4K
Annual income after 10y	$2,467,114,396.16 ✓	$1.04
Total dividends collected	$3742.38M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC
Analyst consensus	Hold	Buy

Year-by-year: MTCR vs ORCC ($10,000, DRIP)

Year	MTCR Portfolio	MTCR Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$45,100	$34,399.72	$11,190	$489.61	+$33.9K → MTCR
2	$193,249	$144,992.35	$12,229	$256.01	+$181.0K → MTCR
3	$787,414	$580,637.11	$13,216	$130.74	+$774.2K → MTCR
4	$3,053,623	$2,211,090.63	$14,207	$66.02	+$3.04M → MTCR
5	$11,281,118	$8,013,740.98	$15,234	$33.17	+$11.27M → MTCR
6	$39,739,462	$27,668,665.51	$16,317	$16.62	+$39.72M → MTCR
7	$133,611,974	$91,090,750.49	$17,468	$8.32	+$133.59M → MTCR
8	$429,193,992	$286,229,179.66	$18,695	$4.16	+$429.18M → MTCR
9	$1,318,524,847	$859,287,275.81	$20,006	$2.08	+$1318.50M → MTCR
10	$3,877,935,983	$2,467,114,396.16	$21,407	$1.04	+$3877.91M → MTCR

MTCR vs ORCC: Complete Analysis 2026

MTCR — Stock

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Full MTCR Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this MTCR vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTCR vs SCHD MTCR vs JEPI MTCR vs O MTCR vs KO MTCR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.